Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001104659-25-061959
Filing Date
2025-06-24
Accepted
2025-06-24 09:00:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 tm2518756d1_424b3.htm 424B3 157652
2 GRAPHIC tm2518756d1_424b3img001.jpg GRAPHIC 3820
  Complete submission text file 0001104659-25-061959.txt   164275
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

EIN.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-288000 | Film No.: 251066873
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)